Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 7Triple Negative Breast Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Neoplasms 1Metastatic Pancreatic Ductal Adenocarcinoma 1Melanoma, Cutaneous Malignant 1Head and Neck Neoplasms 1GastroEsophageal Cancer 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1CLDN18.2 Positive 1Anal Cancer Metastatic 1Adenocarcinoma 1

Interventions

pembrolizumab 15Cisplatin 6Cetuximab 5Surveys and Questionnaires 4dostarlimab 3Carboplatin 3abemaciclib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Interviews as Topic 2Docetaxel 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2ulixertinib 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1tipifarnib 1ribociclib 1repotrectinib 1patritumab deruxtecan 1palbociclib 1osimertinib 1olaparib 1niraparib 1nimotuzumab 1monalizumab 1merphos 1ibrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Albumin-Bound Paclitaxel × 30 days × Clear all
NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡